Our findings disclosed the expression of ERα and the ERβ variants ERβ1, ERβ2, and ERβ5 in most of tumours, whilst only a limited positivity emerged for PR and AR, consistent with previous data from us and other groups on hormone receptor status in HGSOCs [9,10,11,12,13,24]. This evidence concerns the gene ESR2 and neoplasm.